Sequential chemoradiotherapy with gemcitabine and cisplatin for locoregionally advanced nasopharyngeal carcinoma

International Journal of Cancer

Volumn 132, Issue 1, 2013, Pages 215-223

  Gu, Mo Fa ^a   Liu, Li Zhi ^a   He, Long Jun ^a   Yuan, Wen Xin ^a   Zhang, Rong ^a   Luo, Guang Yu ^a   Xu, Guo Liang ^a   Zhang, Hua Man ^a   Yan, Chao Xian ^a   Li, Jian Jun ^a  

^a SUN YAT SEN UNIVERSITY CANCER CENTER   (China)

Author keywords

chemotherapy; gemcitabine; nasopharyngeal carcinoma; radiotherapy

Indexed keywords

CISPLATIN; FLUOROURACIL; GEMCITABINE;

ADOLESCENT; ADULT; ARTICLE; CANCER PATIENT; CANCER SURVIVAL; CHEMORADIOTHERAPY; CONSTIPATION; CRANIAL NEUROPATHY; DERMATITIS; DIARRHEA; DRUG EFFICACY; DRUG TOLERABILITY; DYSPHAGIA; FEMALE; HEARING IMPAIRMENT; HUMAN; KIDNEY INJURY; LEUKOPENIA; LIVER INJURY; MAJOR CLINICAL STUDY; MALE; MUCOSA INFLAMMATION; MULTIPLE CYCLE TREATMENT; NASOPHARYNX CARCINOMA; OTITIS MEDIA; PRIORITY JOURNAL; RASH; SKIN FIBROSIS; THROMBOCYTOPENIA; TREATMENT OUTCOME; TRISMUS; VOMITING; XEROSTOMIA;

ADOLESCENT; ADULT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHEMORADIOTHERAPY, ADJUVANT; CISPLATIN; COHORT STUDIES; DEOXYCYTIDINE; DISEASE-FREE SURVIVAL; FEMALE; FLUOROURACIL; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; NASOPHARYNGEAL NEOPLASMS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84868212468     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.27638     Document Type: Article

References (32)

1. Muir CS, Waterhouse J, Mack T,. Cancer incidence in five continents, vol. 5. IARC Scientific Publications No. 88. Lyon: IARC, 1987.
2. Zhang GY, Liu LZ, Wei WH, et al. Radiologic criteria of retropharyngeal lymph node metastasis in nasopharyngeal carcinoma treated with radiation therapy. Radiology 2010; 255: 605-12.
3. Liu L, Liang S, Li L, et al. Prognostic impact of magnetic resonance imaging-detected cranial nerve involvement in nasopharyngeal carcinoma. Cancer 2009; 115: 1995-2003.
4. Rottey S, Madani I, Deron P, et al. Modern treatment for nasopharyngeal carcinoma: current status and prospects. Curr Opin Oncol 2011; 23: 254-8.
5. Al-Sarraf M, LeBlanc M, Giri PG, et al. Chemoradiotherapy versus radiotherapy in patients with advanced nasopharyngeal cancer: phase III randomized intergroup study 0099. J Clin Oncol 1998; 16: 1310-17.
6. Lee AW, Lau WH, Tung SY, et al.; Hong Kong Nasopharyngeal Cancer Study Group. Preliminary results of a randomized study on therapeutic gain by concurrent chemotherapy for regionally advanced nasopharyngeal carcinoma: NPC-9901 Trial by the Hong Kong Nasopharyngeal Cancer Study Group. J Clin Oncol 2005; 23: 6966-75.
7. Lee AW, Tung SY, Chua DT, et al. Randomized trial of radiotherapy plus concurrent-adjuvant chemotherapy vs. radiotherapy alone for regionally advanced nasopharyngeal carcinoma. J Natl Cancer Inst 2010; 102: 1188-98.
8. Leong SS, Wee J, Tay MH, et al. Paclitaxel, carboplatin, and gemcitabine in metastatic nasopharyngeal carcinoma: a phase II trial using a triplet combination. Cancer 2005; 103: 569-75.
9. Foo KF, Tan EH, Leong SS, et al. Gemcitabine in metastatic nasopharyngeal carcinoma of the undifferentiated type. Ann Oncol 2002; 13: 150-6.
10. Ngan RK, Yiu HH, Lau WH, et al. Combination gemcitabine and cisplatin chemotherapy for metastatic or recurrent nasopharyngeal carcinoma: report of a phase II study. Ann Oncol 2002; 13: 1252-8.
11. Wang CC, Chang JY, Liu TW, et al. Phase II study of gemcitabine plus vinorelbine in the treatment of cisplatin-resistant nasopharyngeal carcinoma. Head Neck 2006; 28: 74-80.
12. Ou D, He X, Hu C, et al. Induction chemotherapy with cisplatin and gemcitabine followed by radiotherapy for locally advanced nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys 2009; 75: S404-S405.
13. Xiayun H, Ou D, Ying H, et al. Experience with combination of cisplatin plus gemcitabine chemotherapy and intensity-modulated radiotherapy for locoregionally advanced nasopharyngeal carcinoma. Eur Arch Otorhinolaryngol 2012; 269: 1027-33.
14. Ma J, Mai HQ, Hong MH, et al. Results of a prospective randomized trial comparing neoadjuvant chemotherapy plus radiotherapy with radiotherapy alone in patients with locoregionally advanced nasopharyngeal carcinoma. J Clin Oncol 2001; 19: 1350-7.
15. Tsao SY,. Technical details for radiotherapy delivery. In:, van Hasselt CA, Gibb AG, eds. Nasopharyngeal carcinoma. Hong Kong: The Chinese University Press, 1991. 207-8.
16. Miller AB, Hoogstraten B, Staquet M, et al. Reporting results of cancer treatment. Cancer 1981: 47: 207-14.
17. Cox JD, Stetz J, Pajak TF,. Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC). Int J Radiat Oncol Biol Phys 1995; 31: 1341-6.
18. Therasse P, Arbuck SG, Eisenhauer EA, et al. New guidelines to evaluate the response to treatment in solid tumors. J Natl Cancer Inst 2000; 92: 201-16.
19. Razak AR, Siu LL, Liu FF, et al. Nasopharyngeal carcinoma: the next challenges. Eur J Cancer 2010; 46: 1967-78.
20. Peters GJ, Bergman AM, Ruiz van Haperen VW, et al. Interaction between cisplatin and gemcitabine in vitro and in vivo. Semin Oncol 1995; 22: 72-9.
21. Luo RX, Tang QX, Huang YW, et al. Comparison of continuous and split-course radiotherapy for nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys 1989; 16: 307-10.
22. Luo RX, Tang QX, Guo KP, et al. Comparison of continuous and split-course radiotherapy for nasopharyngeal carcinomaa-an analysis of 1446 cases with squamous cell carcinoma grade 3. Int J Radiat Oncol Biol Phys 1994; 30: 1107-9.
23. Azli N, Armand JP, Rahal M, et al. Alternating chemo-radiotherapy with cisplatin and 5-fluorouracil plus bleomycin by continuous infusion for locally advanced undifferentiated carcinoma nasopharyngeal type. Eur J Cancer 1992; 28: 1792-7.
24. Wee J, Tan EH, Tai BC, et al. Randomized trial of radiotherapy versus concurrent chemoradiotherapy followed by adjuvant chemotherapy in patients with American Joint Committee on Cancer/International Union against cancer stage III and IV nasopharyngeal cancer of the endemic variety. J Clin Oncol 2005; 23: 6730-8.
25. Yau TK, Lee AW, Wong DH, et al. Treatment of stage IV(A-B) nasopharyngeal carcinoma by induction-concurrent chemoradiotherapy and accelerated fractionation: impact of chemotherapy schemes. Int J Radiat Oncol Biol Phys 2006; 66: 1004-10.
26. Viani GA, Afonso SL, Tavares VC, et al. Weekly gemcitabine and cisplatin in combination with radiotherapy in patients with locally advanced head-and-neck cancer: phase I study. Int J Radiat Oncol Biol Phys 2011; 81: 231-5.
27. Milas L, Cox JD,. Principles of combining radiation therapy and chemotherapy. In:, Cox JD, Ang KK, eds. Radiation oncology, rationale, technique, results. Mosby: St. Louis, 2003. 108-24.
28. Milas L, Hunter N, Mason KA, et al. Tumor reoxygenation as a mechanism of taxol-induced enhancement of tumor radioresponse. Acta Oncol 1995; 34: 409-12.
29. A trial of adjuvant chemotherapy in nasopharyngeal carcinoma patients with residual Epstein-Barr virus (EBV) DNA following radiotherapy. Available at: http://www.clinicaltrials.gov. Accessed on March 11, 2010.
30. Feng WH, Hong G, Delecluse HJ, et al. Lytic induction therapy for Epstein-Barr virus-positive B-cell lymphomas. J Virol 2004; 78: 1893-902.
31. Liu WM, Fowler DW, Smith P, et al. Pre-treatment with chemotherapy can enhance the antigenicity and immunogenicity of tumours by promoting adaptive immune responses. Br J Cancer 2010; 102: 115-23.
32. Plate JM, Plate AE, Shott S, et al. Effect of gemcitabine on immune cells in subjects with adenocarcinoma of the pancreas. Cancer Immunol Immunother 2005; 54: 915-25.